Clara Greaney

Associate

Clara Greaney

Associate

Clara Greaney is an associate for the Business Law Department at Foley & Lardner LLP. Clara is based in the Denver office where she is a member of the Health Care Practice Group.

In 2019 Clara was selected for the Mayo-Foley Health Law Fellowship, consisting of summer internships with the Mayo Clinic Legal Department in Rochester, Minnesota (2019) and Foley (2020). During this time, she assisted attorneys at both Mayo Clinic and Foley with a broad range of regulatory compliance and transactional matters.

Prior to joining Foley, Clara worked for a Providence Health & Services research organization in Seattle, Washington. In this role, Clara negotiated and drafted clinical research and donation contracts with medical device and pharmaceutical companies. Clara also worked with providers on compliance with federal anti-kickback statutes and Sunshine Act reporting.

Representative Experience

  • Represented Sports Medicine North Orthopedic Surgery, Inc., and its affiliated ambulatory surgery center in their acquisition by Connecticut-based orthopedic and spine care management services organization Spire Orthopedic Partners, a portfolio company of Kohlberg & Co.

Awards and Recognition

  • Recipient, CALI Excellence for The Future Award in Legal Research and Writing; Patients and Providers in Law; US Healthcare System; and Health Law Practice

Presentations and Publications

  • Co-author, “Reproductive Health: Over the Counter Birth Control Pill Supported by FDA Advisory Committees,” Health Care Law Today (May 31, 2023)
  • Co-author, “Mobile Point-Point-of-Care Medical Photography: Legal Considerations for Health Care Providers,” Journal of Legal Medicine (July 17, 2020)
  • Co-author, “Social media and cadaveric dissection: A survey study,” Clinical Anatomy (June 8, 2019)
06 November 2023 Health Care Law Today

CMS’ Making Care Primary (MCP) Model: Applications Due November 30, 2023

The Centers for Medicare and Medicaid Services’ (CMS) new program Making Care Primary (MCP), is anticipated to begin July 1, 2024.
17 July 2023 Health Care Law Today

Key Takeaways from the FDA’s First Draft Guidance on Clinical Trials with Psychedelic Drugs

On June 26, 2023, the U.S. Food and Drug Administration issued its first draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations Guidance for Industry.
31 May 2023 Health Care Law Today

Reproductive Health: Over the Counter Birth Control Pill Supported by FDA Advisory Committees

At the May 9-10, 2023, Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee, U.S. Food and Drug Administration advisers voted that the agency should grant a bid to support making the birth control pill, Opill, available for over-the-counter use.
04 April 2023 Deals and Wins

Foley Represents Transcarent in Acquiring Part of 98point6 for $100M

Foley & Lardner LLP represented health and care experience company Transcarent in acquiring AI-powered virtual care platform capabilities and the care business of 98point6 in a deal worth up to $100 million.
27 February 2023 Health Care Law Today

Health Care & Life Sciences Sector Top Trends for 2023

Foley is primed to strategically advise health care and life sciences companies through every step of their journey and all stages of their lifecycle.
04 May 2022 Article

Health Care & Life Sciences Sector Top Trends for 2022

Foley is primed to strategically advise health care and life sciences companies through every step of their journey and all stages of their lifecycle.